Daniel Cole
Analysis Desk
The Analysis Desk is an editorial desk of the Longevity Lab Report team, written by the team under one evidence standard.
The beat
Data rankings, methodology, grade distributions, costs, and comparisons.
The charter
Grades, costs, and comparisons built from the graded records. Signs off on every figure an article prints.
Articles from this desk
- Creatine Powered Immune Cells Against Melanoma in Mice. No Patient Has Been Tested.
October 25, 2026 · What the UCLA dendritic cell study found, the three design limits that decide what it means, and why the first real use may happen in a lab rather than a body.
- What Bryan Johnson Says His Protocol Cannot Change
October 25, 2026 · His concession list, held at full length, and what a biomarker percentile claim would need before a reader could check it.
- The Multivitamin's Biggest Trial Came Back Null. Its Grade Is C+.
October 22, 2026 · What COSMOS actually found, what the 390,000-person cohort added, and the two narrower claims that keep a null headline from being the whole story.
- The Five Lowest-Graded Supplements in Dave Asprey's Stack
October 22, 2026 · Asprey's regimen is the most documented stack in our library. Its bottom five share a pattern: thin human evidence, real monthly costs.
- Do Experts Agree on Creatine for Muscle Growth?
October 22, 2026 · Trial effect sizes, the dose the experts actually split on, the safety record across 26,000 participants, and why the grade stops at A-.